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Changes of lung parenchyma density
following high dose radiation therapy for
thoracic carcinomas – an automated
analysis of follow up CT scans
Christina Schröder1,2* , Rita Engenhart-Cabillic1, Sven Kirschner3, Eyck Blank3 and André Buchali3
Abstract
Background: An objective way to qualify the effect of radiotherapy (RT) on lung tissue is the analysis of CT scans after
RT. In this analysis we focused on the changes in Hounsfield units (ΔHU) and the correlation with the corresponding
radiation dose after RT.
Methods: Pre- and post-RT CT scans were matched and ΔHU was calculated using customized research software. ΔHU
was calculated in 5-Gy-intervals and the correlation between ΔHU and the corresponding dose was calculated as well as
the regression coefficients. Additionally the mean ΔHU and ΔHU in 5-Gy-intervals were calculated for each tumor entity.
Results: The mean density changes at 12 weeks and 6months post RT were 28,16 HU and 32,83 HU. The correlation
coefficient between radiation dose and ΔHU at 12 weeks and 6months were 0,166 (p = 0,000) and 0,158 (p = 0,000). The
resulting regression coefficient were 1439 HU/Gy (p = 0,000) and 1612 HU/Gy (p = 0,000). The individual regression
coefficients for each patient range from − 2,23 HU/Gy to 7,46 HU/Gy at 12 weeks and− 0,45 HU/Gy to 10,51 HU/Gy at 6
months. When looking at the three tumor entities individually the highest ΔHU at 12 weeks was seen in patients with
SCLC (38,13 HU) and at 6month in those with esophageal carcinomas (40,98 HU).
Conclusion: For most dose intervals there was an increase of ΔHU with an increased radiation dose. This is reflected by a
statistically significant, although low correlation coefficient. The regression coefficients of all patients show large
interindividual differences.
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Background
Radiation therapy (RT) of thoracic tumors is commonly
associated with toxicities of the surrounding organs at
risk. In case of lung or esophageal tumors this usually
refers to radiation-induced lung disease (RILD) like radi-
ation pneumonitis (RP) and lung fibrosis [1–11]. Both
are common RT induced toxicities that can occur either
weeks up to a few months after RT (early side effects,
e.g. RP) or up to years after RT (late side effects, e.g.
fibrosis). Common symptoms include fever, coughing
and shortness of breath. However, not all patients de-
velop clinically apparent symptoms. There is a number
of patients with lung tissue changes that are radiologic-
ally visible but have no clinical correlate. Also, patients
might simply not have yet developed symptoms during
the time of the follow up.
An objective way to qualify the effect of RT on lung tis-
sue that includes subclinical affected patients is the ana-
lysis of CT scans after RT, e.g. focusing on the changes in
Hounsfield units (ΔHU) over time. Although this method
might be too complex to implement it into the daily clin-
ical routine, it is a very useful tool if a detailed and object-
ive evaluation is needed. Unfortunately there is no
commercially available software for the automated analysis
of lung tissue changes. For research purposes custom
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software has to be developed for both the matching of
pre- and post-RT CT scans and the calculation of the lung
tissue density changes. As a result there have only been a
few trials focusing on lung density changes after RT and
among those even less have used an automated analysis or
focused on the correlation between density changes and
radiation dose [12–21]. Although there are numerous
dose constraints regarding severe clinical side effects such
as RP, the question remains if there is a correlation be-
tween the visible tissue damage and the corresponding ra-
diation dose. Also, how does the lung density after RT
change over time? To answer these questions we analyzed
CT after treatment by matching the patients’ follow-up
CT with the treatment planning CT and calculating the
changes in HU over the course of 6months. Also, we
matched the changes in HU to the underlying radiation
dose according to the Dose-Volume-Histogram (DVH).
Methods
Patient characteristics
Included in this analysis were the CT scans of curatively
treatable patients with intrathoracical carcinoma
(NSCLC, SCLC, esophageal carcinoma) with a written
consent of participation and a Karnofsky index (KI) of at
least 70%. Patients with a lung operation in the patient’s
medical history, a relevant pleural effusion visible in the
planning CT, a forced expiratory volume in 1 s (FEV1) of
less than 1 l, the refusal of participation or a KI of less
than 70% were excluded. From April 2012 to October
2015 81 patients with thoracic carcinomas received ra-
dio-(chemo-)therapy according to intradepartmental
standards. The median age of patients was 66 years.
Most patients had NSCLC (n = 35) or esophageal cancer
(n = 35), followed by SCLC (n = 11). All patients com-
pleted the treatment protocol. Follow up CT scans were
performed 12 weeks and 6months after RT. CT data of
61 patients was available 12 weeks after RT and data of
51 patients 6 months after RT. Further patient character-
istics are shown in Table 1.
Treatment characteristics
NSCLC patients were treated with a total radiation dose of
74 Gy, SCLC patients with 60Gy and patients with esopha-
geal carcinoma with 66Gy. Fraction dose was 2 Gy each.
All treatment plans had to match intradepartmental dose
constraints and were identically standardized using the
PTV. Dose constraints for the lung were V20Gy < 30%,
V30Gy < 20% and V20Gy < 1000ml; for the spinal cord a
maximum dose (Dmax) of < 47Gy; for the esophagus a
Dmax < 74Gy and for the heart a mean dose (Dmean) of
< 35Gy, D(33%) < 60Gy und D(50%) < 45Gy. All these
dose values refer to biological doses. Eligible patients
received chemotherapy according to intradepartmental
standards.
Analysis of follow up CT scans
Follow up CTs were done 12 weeks and 6months after
RT. For all CT scans a Sensation Open CT (Siemens™)
with 2mm slices was used. To calculate the density
changes of the lung tissue over time a patient’s follow up
CTs had to be matched to the original treatment plan-
ning CT. Because of the slightly different positioning
and breathing position of a patient at each scan, the de-
formation of one of the scans was necessary prior to the
matching. Since the treatment planning CT was linked
to the dose data and structure files the follow up CT
had to get deformed. To calculate the differences in lung
density (in Hounsfield units) the treatment planning and
Table 1 Patient characteristics
n (%)
Sex
male 65 (80,2%)
female 16 (19,8%)
Chemotherapy
no 23 (28,4%)
yes 58 (71,6%)
Entity (total radiation dose)
SCLC (60 Gy) 11 (13,6%)
Esophageal CA (66 Gy) 35 (43,2%)
NSCLC (74 Gy) 35 (43,2%)
Smoking history
never 6 (7,4%)
present 39 (48,1%)
former 34 (42,0%)
unknown 2 (2,5%)
T
1 3 (3,7%)
2 9 (11,1%)
3 48 (59,3%)
4 21 (25,9%)
N
0 3 (3,7%)
1 32 (39,5%)
2 15 (18,5%)
3 31 (38,3%)
M
0 63 (77,8%)
1 18 (22,2%)
Treatment technique
IMRT 43 (53,1%)
VMAT (rapid arc) 38 (46,9%)
Total 81 (100,0%)
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the follow up scans were automatically subtracted. Be-
cause there was a focus on changes in the lung paren-
chyma, structures with higher density like the tumor
itself, other organs, blood vessels etc. were also sub-
tracted from the analyzed volume including a small
safety margin. As mentioned before there is no commer-
cial software available so research software had to be
customized. This included CERR (Computational Envir-
onment for Radiotherapy Research), an open source li-
brary for medical research by the US National Institutes
of Health and 3D-Slicer, also open source library for
medical research by the National Alliance for Medical
Image Computing (NA-MIC). The original data sets
were imported, analyzed and the calculated ΔHU values
were exported into Microsoft Excel and SPSS for further
analysis. In this analysis we focused on mean density
changes 12 weeks and 6months post RT. For further
analysis the mean density changes were additionally cal-
culated in 5-Gy intervals. The correlation between ΔHU
and the corresponding dose was calculated as well as the
corresponding regression coefficients. Also the individ-
ual regression coefficients were calculated for each pa-
tient. Since this analysis was done with patients being
treated for 3 different tumor entities (NSCLC, SCLC,
esophageal carcinoma) with resulting different total
treatment doses, the mean overall density changes and
the density changes in 5-Gy intervals were calculated for
each tumor entity as well.
Statistical analysis
For the comparison of the mean density changes at 12
weeks and 6months post RT as well as the tumor entity
the T-Test was used. Spearman correlation was used to
analyze the correlation between the lung density changes
and the radiation dose. Regression was done using a linear
regression model without a constant. For statistical analysis
Microsoft Excel 2008 and SPSS Version 23 were used.
Results
Overall, 90% of the values for the density changes of the
lung parenchyma range between 0 HU and 300 HU.
About 5% of the values were negative, the majority of
those between − 100 HU and 0 HU. The mean density
changes at 12 weeks post RT were 28,16 HU and 32,83
HU at 6months post RT. For further analysis the mean
density changes were calculated in 5-Gy intervals. Fig-
ure 1 shows the mean lung tissue density changes with
their corresponding 95% confidence interval (CI) for all
data and Fig. 2 shows the curves for 12 weeks and 6
months separately.
The correlation coefficient between radiation dose and
density changes of the lung parenchyma for all available
values was 0,162 (p = 0,000). When looking at 12 weeks
and 6months individually the coefficients were 0,166 (p =
0,000) and 0,158 (p = 0,000). The resulting regression coef-
ficient was 1516 HU/Gy (p = 0,000) for all values and 1439
HU/Gy (p = 0,000) and 1612 HU/Gy (p = 0,000) when
looking at 12 weeks and 6months separately. The individ-
ual regression coefficients for each patient range from −
2,23 HU/Gy to 7,46 HU/Gy at 12 weeks and − 0,45 HU/
Gy to 10,51 HU/Gy at 6 months. Figure 3 shows the distri-
bution of the regression coefficients of patients.
When looking at the three tumor entities individually
the highest ΔHU at 12 weeks was seen in patients with
SCLC (38,13 HU) followed by patients with NSCLC
(27,08 HU) and esophageal carcinomas (24,42 HU). At
6 months the patients with the highest ΔHU were those
with esophageal carcinomas (40,98 HU) followed by
those with NSCLC (31,57 HU) and SCLC (23,10 HU).
There was a statistically significant difference for the
mean density changes between the tumor entities at 12
weeks as well as 6 months post RT (p = 0,000). Figures 4
and 5 show the mean density changes for the tumor en-
tities 12 weeks and 6months post RT (with 95% CI).
Discussion
The analysis of post RT CT scans is associated with a lot of
challenges deriving from the interindividual differences, the
question of background correction and the questionable
correlation with clinical symptoms [12–14].
To avoid inaccuracies due to patient positioning and
breathing an additional margin was added around the
tumor itself and the large intrapulmonary structures like
bronchi and vessels before subtraction of the CT scans.
A more detailed approach would include repetitive CT
scans of a patient, preferably without structural lung
damage to determine the background, which is ethically
problematic. With the assumption that possible inaccur-
acies equally lead to a density increase and decrease the
original data sets without any background correction
were used for this analysis.
Regarding the influence of the radiation dose on the
mean density changes there was an increase in lung density
for increasing radiation doses for most dose intervals. For a
radiation dose of lower than 10Gy there was an initial de-
crease in ΔHU. Generally an increase of lung density with
increasing radiation dose has been described before [12–16,
22]. Overall the curve is not linear but resembles a sigmoid
curve. A sigmoid dose responds curve has been discussed
before by Defraene et al. and Bernchou et al. [13, 22]. The
initial decrease for low doses might be due to background
noise but could also indicate the existence of a threshold
for radiation induced density changes. There is not much
data on this topic. The data that have been published show
a wide range of possible thresholds from under 5–10Gy to
30–40Gy [13, 14, 16]. This range is most likely the result of
different methods of data analysis but might also be con-
nected to the great interindividual differences described by
Schröder et al. Radiation Oncology           (2019) 14:72 Page 3 of 7
de Ruysscher et al. [12] and also seen in this analysis.
Another hypothesis for the initial decrease is that shrinkage
in the high dose areas and a reduced pulmonary function
as a result of a fibrosis leads to a compensatory overinfla-
tion of lung tissue in the low dose areas. When looking at
the density changes over time, the curves for the mean
density changes 12 weeks and 6months post RT overlap
between 25Gy and 50Gy. For dose values lower than 25
Gy and higher than 50Gy there is a greater increase in
mean density 6months after RT. The high dose areas are
more important for fibrotic changes, which is a late toxicity
and according to Krengli et al. has a threshold at about 25
Gy [3, 19, 23, 24]. At 12 weeks the dominant lung toxicity
is the RP, which also leads to an increase lung tissue density
due to edema. These changes also occur in areas receiving
a lower radiation dose [2, 5, 6, 24]. Therefore the density
Fig. 1 Lung density after RT (with 95% CI)
Fig. 2 Lung density changes 12 weeks and 6months after RT (with 95% CI)
Schröder et al. Radiation Oncology           (2019) 14:72 Page 4 of 7
changes for the intermediate dose intervals overlap due to
the density changes at 12 weeks as a result of edema and
beginning structural changes and at 6months due to
advanced structural changes. At higher doses the fibrotic
changes are even greater resulting in a higher mean density
as compared to 12weeks. At doses of lower than 25Gy
there is the problem of background noise and a possible
threshold for RT induced density changes. Nevertheless the
higher mean density changes 6months post RT might be
the result of more advanced structural changes.
Fig. 3 Overview of regression coefficients of patient
Fig. 4 ΔHU 12 weeks after RT for each tumor entity (with 95% CI, n = 62)
Schröder et al. Radiation Oncology           (2019) 14:72 Page 5 of 7
The correlation between lung density changes and radi-
ation dose is statistically significant, although the correl-
ation coefficient is 0,162 and therefore not suggesting a
very high level of interaction. Also the overall regression
coefficient of 1516 HU/Gy shows that the increase of the
mean density with increasing radiation dose is not steep.
The individual coefficients range from − 2,23 HU/Gy to
7,46 HU/Gy 12 weeks post RT and − 0,45 HU/Gy to 10,51
HU/Gy 6months post RT, which shows the underlying
interindividual variability. About 75% of patients had a re-
gression coefficient between 0 and 3 at 12 weeks and 6
months suggesting that the majority of patients only show
a modest increase in lung density after RT. A similar result
has already been published before by de Ruysscher et al.
with a mean regression coefficient of 1,8 (SD 2,1 HU/Gy)
and 1,4 (SD 1,3 HU/Gy) [12].
There is a statistically significant difference of the mean
density changes between the 3 tumor entities. However
there is no consistency as to patients with which entity
show the largest increase in lung tissue density. 12 weeks
post RT the largest mean increase was seen in patients with
SCLC, 12 weeks post RT in patients with esophageal car-
cinomas. This might simply be due to the fact that the total
treatment doses are different and therefore the resulting
biologically equivalent doses differ as well. Another factor
might be that in this cohort patients with NSCLC and
SCLC have a pathology of the lung itself and therefore the
density changes are not solely the result of RT induced tox-
icity but also the tumor itself. In general it is questionable if
the differences between the tumor entities are not only
statistically significant but clinically relevant as well.
Conclusion
For most dose intervals there is an increase of lung density
with an increased radiation dose. Due to possible back-
ground noise a definite statement regarding a threshold for
RT induced density changes is difficult. The dose-volume
relationship is reflected by a statistically significant,
although low correlation coefficient. The regression coeffi-
cient further describes the relationship between dose and
corresponding lung density and shows large interindividual
differences. When looking at the mean density changes
over time the resulting curves overlap for doses between
25 and 50 Gy, possibly as a result of a density increase due
to edema (12 weeks post RT) and structural changes (6
months). Higher mean density changes 6months post RT
are most likely the result of more advanced structural
changes, as lung fibrosis typically is a late toxicity. The sig-
nificant differences between the mean density of patients
with SCLC, NSCLC and esophageal carcinomas might
simply be the result of additional density changes due to
the tumor itself in patients with lung carcinomas.
Abbreviations
CT: Computed tomography; DVH: Dose-volume-histogram; Gy: Gray;
HU: Hounsfield units; KI: Karnofsky index; NSCLC: Non-small cell lung cancer;
RILD: Radiation-induced lung disease; RP: Radiation pneumonitis;
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Fig. 5 ΔHU 6months after RT for each tumor entity (with 95% CI, n = 51)
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